Anti-CCL2 (Carlumab) -SMCC-DM1
Product Specifications
Target
CCR, Microtubule Associated, Antibody-Drug Conjugates (ADCs)
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related, Microbiology/Virology, Cytoskeletal Signaling, GPCR/G Protein
Bioactivity
Anti-CCL2 (Carlumab) -SMCC-DM1 is an antibody-drug conjugate (ADC) consisting of the human-derived anti-CCL2 (chemokine ligand 2) antibody Carlumab linked to the cytotoxic microtubule inhibitor DM1 through the linker SMCC. The ADC's toxic molecule and linker component are SMCC-DM1. This compound is applicable in cancer research, particularly for studying prostate cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400204-500 1x 500 µL
Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740204-100 1x 100 µL
Complement C4d (C4D204), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741124-500 1x 500 µL
TOX3 (TOX3/1124), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details